Archives
1. Can you share with us what retinal eye disease you have and when you were diagnosed? When I was 15, I was diagnosed with cataracts. I woke up one morning with…
READ MORE about Youth Space Spotlight: Cathy
An additional treatment option for people with wet age-related macular degeneration (AMD) will soon be available in Canada. Health Canada has just approved Eyelea, a drug made and marketed by Bayer Inc….
READ MORE about Eyelea Approved to Treat Wet AMD in Canada
A $5 million grant from Alberta’s provincial health funder is establishing a Canadian Centre of Excellence for ocular gene therapy research. Drs. Ian MacDonald and Tania Bubela at the University of Alberta…
READ MORE about Ocular Gene Therapy Centre Established at U of A
Almost three years ago, scientists at the University of Massachusetts Medical School reported on a preliminary clinical trial of the epilepsy drug, valproic acid, as potential treatment for autosomal dominant retinitis pigmentosa…
READ MORE about Valproic Acid: The Perils of Using Drugs Off-Label
Dr. Ian MacDonald and his team at the University of Alberta are internationally recognized experts in the study of choroideremia, a rare blinding disease that typically affects young men beginning in adolescence….
READ MORE about The Genetics of ChoroideremiaJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
